Almirall is a dynamic, international company that strives for innovation through its innovative products in respiratory medicine. Treatment of airway diseases has been one of Almirall’s major areas of focus, and significant human and financial resources are being dedicated to research in this field. Almirall researches, develops, manufactures and commercialises its own R&D drugs and other licensed drugs, with the aim of improving people’s health and wellbeing. The on-going commitment, excellence and creative power of our people have made Almirall a first-class and fast-growing pharmaceutical company.
Novartis provides innovative healthcare solutions that address the evolving needs of patients and societies. Headquartered in Basel, Switzerland, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, eye care, cost-saving generic pharmaceuticals, preventive vaccines and diagnostic tools, over-the-counter and animal health products. Novartis is the only global company with leading positions in these areas. In 2010, the Group's continuing operations achieved net sales of USD 50.6 billion, while approximately USD 9.1 billion (USD 8.1 billion excluding impairment and amortization charges) was invested in R&D throughout the Group. Novartis Group companies employ approximately 121,000 full-time-equivalent associates and operate in more than 140 countries around the world. For more information, please visit http://www.novartis.com
Boehringer Ingelheim is a research-driven company dedicated to researching and developing, manufacturing and marketing pharmaceuticals that improve health and quality of life. Our businesses are human pharmaceuticals and animal health. The company is committed to deliverin high quality products that provide benefit to patients and healthcare providers.
At Pfizer, we apply science and our global resources to improve health and well-being at every stage of life. We strive to set the standard for quality, safety and value in the discovery, development and manufacturing of medicines.
GlaxoSmithKline UK - Do more, feel better, live longer
About us
GlaxoSmithKline — one of the world's leading research-based pharmaceutical and healthcare companies — is committed to improving the quality of human life by enabling people to do more, feel better and live longer. We have offices across the UK and we are committed to working with the NHS to improve patient healthcare. If you would like more information about GlaxoSmithKline, please visit our global corporate web site.
You are viewing the text version of this site.
To view the full version please install the Adobe Flash Player and ensure your web browser has JavaScript enabled.
Need help? check the requirements page.